PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures
出版年份 2020 全文链接
标题
PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures
作者
关键词
-
出版物
BMC BIOINFORMATICS
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-06
DOI
10.1186/s12859-020-03568-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Connecting genetics and gene expression data for target prioritisation and drug repositioning
- (2018) Enrico Ferrero et al. BioData Mining
- PI3Kβ inhibitor AZD6482 exerts antiproliferative activity and induces apoptosis in human glioblastoma cells
- (2018) Peng-Fei Xu et al. ONCOLOGY REPORTS
- A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
- (2017) Andrea Wang-Gillam et al. JOURNAL OF CLINICAL ONCOLOGY
- Pimozide reduces toxic forms of tau in TauC3 mice via 5′ adenosine monophosphate-activated protein kinase-mediated autophagy
- (2017) Young Doo Kim et al. JOURNAL OF NEUROCHEMISTRY
- Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry
- (2017) Hon-Cheong So et al. NATURE NEUROSCIENCE
- WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research
- (2017) Denise N Slenter et al. NUCLEIC ACIDS RESEARCH
- The Reactome Pathway Knowledgebase
- (2017) Antonio Fabregat et al. NUCLEIC ACIDS RESEARCH
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Kinase gene fusions in defined subsets of melanoma
- (2017) Jacqueline Turner et al. Pigment Cell & Melanoma Research
- Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3
- (2016) Duanmin Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Predicting microRNA-disease associations based on improved microRNA and disease similarities
- (2016) Wei Lan et al. IEEE-ACM Transactions on Computational Biology and Bioinformatics
- Open Targets: a platform for therapeutic target identification and validation
- (2016) Gautier Koscielny et al. NUCLEIC ACIDS RESEARCH
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Targeting WEE1 Kinase in Cancer
- (2016) Christopher J. Matheson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
- (2016) Zichen Wang et al. Nature Communications
- The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins
- (2016) Andrew D. Rouillard et al. Database-The Journal of Biological Databases and Curation
- PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas
- (2016) Małgorzata Czyż et al. Oncotarget
- The MLN4924 inhibitor exerts a neuroprotective effect against oxidative stress injury via Nrf2 protein accumulation
- (2016) Ana Cristina Andérica-Romero et al. Redox Biology
- DSigDB: drug signatures database for gene set analysis: Fig. 1.
- (2015) Minjae Yoo et al. BIOINFORMATICS
- A survey of current trends in computational drug repositioning
- (2015) Jiao Li et al. BRIEFINGS IN BIOINFORMATICS
- Integrative Data Analysis of Multi-Platform Cancer Data with a Multimodal Deep Learning Approach
- (2015) Muxuan Liang et al. IEEE-ACM Transactions on Computational Biology and Bioinformatics
- Synaptic structure and function are altered by the neddylation inhibitor MLN4924
- (2015) Samantha L. Scudder et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic
- (2015) T Lencz et al. MOLECULAR PSYCHIATRY
- An analysis of the attrition of drug candidates from four major pharmaceutical companies
- (2015) Michael J. Waring et al. NATURE REVIEWS DRUG DISCOVERY
- Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
- (2015) Adam A. Friedman et al. PLoS One
- In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug
- (2015) Xi-Nan Shi et al. PLoS One
- Use of Genome-Wide Association Studies for Cancer Research and Drug Repositioning
- (2015) Jizhun Zhang et al. PLoS One
- Drug Repositioning for Diabetes Based on 'Omics' Data Mining
- (2015) Ming Zhang et al. PLoS One
- GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database
- (2014) R. Leslie et al. BIOINFORMATICS
- Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers
- (2014) Michael K Wendt et al. BREAST CANCER RESEARCH
- Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1 and Oxidative Phosphorylation in Melanoma
- (2014) Y. N. V. Gopal et al. CANCER RESEARCH
- SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer
- (2014) V. P. S. Ghotra et al. CANCER RESEARCH
- Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study
- (2014) Sachin P. Patil et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease
- (2014) Bellinda Benhamú et al. JOURNAL OF MEDICINAL CHEMISTRY
- LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
- (2014) Qiaonan Duan et al. NUCLEIC ACIDS RESEARCH
- Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1–7)
- (2014) Mohammad M. Abd-Alhaseeb et al. PLoS One
- Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
- (2014) Thomas Wiesner et al. Nature Communications
- The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication
- (2013) Mathias Rask-Andersen et al. Annual Review of Pharmacology and Toxicology
- The toxicity of nitrofuran compounds on melanoma and neuroblastoma cells is enhanced by Olaparib and ameliorated by melanin pigment
- (2013) Ewan M. McNeil et al. DNA REPAIR
- Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance
- (2013) Irina Lonskaya et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model
- (2013) O. Surriga et al. MOLECULAR CANCER THERAPEUTICS
- Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data
- (2013) Joshua C Denny et al. NATURE BIOTECHNOLOGY
- The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
- (2013) Danielle Welter et al. NUCLEIC ACIDS RESEARCH
- The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice
- (2013) Atsushi Masamune et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- UniChem: a unified chemical structure cross-referencing and identifier tracking system
- (2013) Jon Chambers et al. Journal of Cheminformatics
- graphite - a Bioconductor package to convert pathway topology to gene network
- (2012) Gabriele Sales et al. BMC BIOINFORMATICS
- Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug
- (2012) Hee Lee et al. BMC Systems Biology
- Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells
- (2012) Denis Selimovic et al. CELLULAR SIGNALLING
- Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor
- (2012) H. Y. Zou et al. MOLECULAR CANCER THERAPEUTICS
- Use of genome-wide association studies for drug repositioning
- (2012) Philippe Sanseau et al. NATURE BIOTECHNOLOGY
- Preclinical Pharmacokinetic and Pharmacodynamic Evaluation of Novel Anticancer Agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for Brain Tumor Chemotherapy
- (2012) Silpa Nuthalapati et al. PHARMACEUTICAL RESEARCH
- Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth
- (2012) Zhen Hua Wu et al. PLoS One
- A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
- (2012) Jose Miguel Rubio-Perez et al. TheScientificWorldJOURNAL
- Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells
- (2012) Ting Zhou et al. TUMOR BIOLOGY
- Exploiting drug-disease relationships for computational drug repositioning
- (2011) J. T. Dudley et al. BRIEFINGS IN BIOINFORMATICS
- Inhibition of Wnt/β-Catenin Signaling by p38 MAP Kinase Inhibitors Is Explained by Cross-Reactivity with Casein Kinase Iδ/ɛ
- (2011) Folkert Verkaar et al. CHEMISTRY & BIOLOGY
- Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
- (2011) Kentaro Yamanaka et al. CLINICAL CANCER RESEARCH
- Breast Cancer-Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown
- (2011) S. Previdi et al. MOLECULAR CANCER THERAPEUTICS
- Fighting neurodegeneration with rapamycin: mechanistic insights
- (2011) Jordi Bové et al. NATURE REVIEWS NEUROSCIENCE
- GWASdb: a database for human genetic variants identified by genome-wide association studies
- (2011) Mulin Jun Li et al. NUCLEIC ACIDS RESEARCH
- DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome
- (2011) Heng Luo et al. NUCLEIC ACIDS RESEARCH
- Systematic Drug Repositioning Based on Clinical Side-Effects
- (2011) Lun Yang et al. PLoS One
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- Histamine receptors in the CNS as targets for therapeutic intervention
- (2011) Maria Beatrice Passani et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inflammation and Alzheimer’s disease
- (2010) Young-Jung Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Modeling sample variables with an Experimental Factor Ontology
- (2010) James Malone et al. BIOINFORMATICS
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Discovery of drug mode of action and drug repositioning from transcriptional responses
- (2010) F. Iorio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Network-Based Elucidation of Human Disease Similarities Reveals Common Functional Modules Enriched for Pluripotent Drug Targets
- (2010) Silpa Suthram et al. PLoS Computational Biology
- Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor
- (2009) Peter Gimsing EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
- (2009) Karl D. Lewis et al. INVESTIGATIONAL NEW DRUGS
- Predicting new molecular targets for known drugs
- (2009) Michael J. Keiser et al. NATURE
- A novel signaling pathway impact analysis
- (2008) Adi Laurentiu Tarca et al. BIOINFORMATICS
- Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study
- (2008) Chris Twelves et al. EUROPEAN JOURNAL OF CANCER
- Genetics of gene expression and its effect on disease
- (2008) Valur Emilsson et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now